Next Generation Antimicrobial Matrix
Microlyte® Matrix absorbs wound fluid and transforms into a bioresorbable gel that intimately contours to the underlying wound bed. It maintains a physiologically moist microenvironment. In vitro and in vivo, studies indicate that components of the matrix allow cell growth and neovascularization. 1,2,3
Bioresorbable Matrix
100% bioresorbable polymer matrix eliminates the need to remove residual matrix from the wound2
Contours to Wound Bed
Absorbs wound fluid and serves as scaffold for cell migration, vascularization, granulation tissue formation1,2
Transparent & Synthetic
Allows for clear view of wound bed, isn’t of human or animal origin, and holds a long room-temp. shelf life6
Low Residual Toxicity
Less wound staining and needs only ˜1 µg/cm² Ag+ to kill microbes on the tissue surface7
Clinically-Proven
Thirty-two patients with a total of 35 chronic, nonhealing wounds of varying types were treated with Microlyte® Matrix once every three days. At 3 weeks, 72% of wounds had significantly improved healing with an average wound area reduction of 66%. By 12 weeks, 91% of wounds either healed completely or improved significantly with an average wound area reduction of 73%. The application of Microlyte® Matrix was safe and well tolerated, and it facilitated improvements in healing of a majority of the complex chronic wounds studied. Click below to read the full article from the November issue of WOUNDS.
Latest News
REFERENCES 1 A Agarwal, et al. Biomaterials, 31 (4), 680-690, 2010. 2 Systemic Toxicity, Local Tissue Response, and Wound Healing Study of Microlyte Ag wound dressing, Following Repeated Treatment to Full-Thickness Wounds in Rats – 28 Days. Study 15T_41113_02, 2015. Data on file, Imbed Biosciences. 3 MTT cytotoxicity testing conducted at NAMSA. Data on file at Imbed Biosciences. 4 FDA 510k application. Data on file, Imbed Biosciences. 5 As demonstrated in vitro